Jason A. Leverone, Chief Financial Officer at OnKure Therapeutics, sold OKUR on Sep 21, 2026
Data as of Oct 27
▼ SELL$898302 shares at $2.97Jason A. Leverone Chief Financial OfficerOKUR OnKure Therapeutics, Inc.
- Traded
- Sep 21, 2026
- Disclosed
- Sep 23, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
OKUR since disclosure
−11.7%
after the sale
Similar stocks (SPY) since disclosure
+0.2%
S&P 500 (SPY)
Change in closing price from Sep 23, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.